scma原理

Searching…

pubmed.ncbi.nlm.nih.gov

Treatment of tardive dyskinesia with tetrabenazine or ...

Up to 30% of patients taking antipsychotics may develop tardive dyskinesia (TD). Recent evidence-based recommendations demonstrate an unmet need for effective TD management. This systematic review was designed to upda...

www.uspharmacist.com

Treatment Strategies for Tardive Dyskinesia - U.S. Pharmacist

May 14, 2025 · US Pharm. 2025;50 (5):HS2-HS5. ABSTRACT: Tardive dyskinesia (TD) is a potentially permanent neurologic disorder that is primarily associated with dopamine receptor antagonists, most commonly antipsychot...